C B PHARMA ACQUISITION CORP's ticker is CNLMU and the CUSIP is G2029P100. A total of 13 filers reported holding C B PHARMA ACQUISITION CORP in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $150,000 | – | 14,900 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENECA CAPITAL INVESTMENTS, L.P. | 150,000 | $1,579,000 | 0.30% |
| GLAZER CAPITAL, LLC | 220,260 | $2,176,000 | 0.24% |
| Polar Asset Management Partners Inc. | 200,000 | $2,113,000 | 0.09% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 350,000 | $3,668,000 | 0.06% |
| GOLDMAN SACHS GROUP INC | 17,500 | $183,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 38 | $0 | 0.00% |
| UBS Group AG | 210 | $2,000 | 0.00% |